All Posts
-
Shugarcaine
The medicine with a curious name – Shugarcaine -- was the first anesthesia developed for use inside the eye.
-
The Salt City
Edge Pharma’s sales, marketing, and customer service teams are headquartered in Syracuse, in the rolling hills of Central New York State, between the Finger Lakes and the Adirondack Mountains.
-
Effect of norepinephrine dosage on mortality in patients with septic shock
Click the link to read an interesting article published in February 2018 in the Journal of Intensive Care entitled, "Effect of Norepinephrine Dosage on Mortality in Patients with Septic Shock."...
-
Allergy Vial Labels
Accurate and clearly printed allergy vial labels are important for patient safety, compliance with USP guidelines, and liability exposure of the practice.
-
Edge Expects Continued Strong Growth
Serving thousands of hospitals, surgery centers, and clinics nationwide, Edge Pharma continues to rapidly grow. With product lines spanning 14 medical specialties, almost 100 standard products, a comprehensive suite of...
-
Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis
Click the link to read a Mayo Clinic study entitled, “Safety and Efficacy of Intravesical Alum for Intractable Hemorrhagic Cystitis: A Contemporary Evaluation.” This study identified patients given intravesical alum...
-
Allergy Immunotherapy in the United States
Click the link below to read a brief summary of a new report from Future Market Insights that analyzes the allergy immunotherapy market in the United States.
-
Colchester, Vermont
Edge Pharma’s headquarters and manufacturing facilities are located in historic Colchester, Vermont, in the picturesque Northwest corner of the state.
-
William Chatoff, CEO Edge Pharma
Perseverance, along with a liberal dose of curiosity, seem to be driving influences in the career of Edge Pharma CEO William Chatoff, a licensed pharmacist and nuclear pharmacist.
-
503B Outsourcing
In the midst of the coronavirus pandemic, it’s understandable that there is an increased focus on all aspects of our healthcare system – including patient care, providers, healthcare facilities, medicines,...
-
Coronavirus Response from Edge Pharma
In the past few weeks, the news of the spread and extent of the novel coronavirus has been alarming and sobering.
-
Endophthalmitis Overview
Almost 30 million Americans are affected by cataracts, and with the aging of the population, that number is projected to rise dramatically within the next few decades.
-
Edge now offers allergenic extracts in bulk vials
Edge Pharmaceuticals now offers a wide range of allergenic extracts in bulk vials, for use in skin test diagnosis, as well as immunotherapy for patients with allergies.
-
Sterile Alum Solution is now in stock
Sterile Concentrated Alum Solution is now in stock and ready to ship from Edge Pharma. For any hospital pharmacy currently struggling with nonsterile to sterile compounding of this important medication,...
-
Sterile Glycerin 99% Injection and Sterile Phenol 6% Injection Now Available
Edge Pharma is excited to announce the availability of two new products: Sterile Glycerin 99% Injection and Sterile Phenol 6% Injection.
-
Edge Pharmaceuticals offers allergy vials and diluents
Edge now offers allergy vials and diluents for both private allergy practices and hospitals. Click the link to learn more about our sealed sterile empty glass vials, which come in...
-
New metered dose bottles with pumps now available
For allergy providers and clinics, click the link to learn more about Sublingual Immunotherapy (SLIT) metered dose bottles with pumps from Edge Pharmaceuticals, the leader in allergy supplies.With decades of...
-
Edge Pharma is excited to support a great organization called See International
Edge Pharma is excited to support a great organization called See International, a nonprofit dedicated to restoring sight and preventing blindness in underserved locations around the world.
-
Edge Pharma is excited to announce the acquisition of Edge Pharmaceuticals
Edge Pharma, LLC, a leader in providing allergy immunotherapy solutions, is excited to announce the acquisition of Florida-based Edge Pharmaceuticals, LLC.
-
Edge Pharma is preparing an ANDA submission for FDA approval of methacholine chloride
Edge Pharma, one of the leaders in 503B pharmaceutical outsourcing, is excited to announce that it is preparing the required ANDA submissions to the FDA for approval of a generic...
-
New Allergy Treatment Program Aims to Improve Patient Care and Reduce Healthcare Costs
Edge is excited to announce an investment in Xtract Solutions, an allergy software solution provider based in Beaverton, Oregon.
-
Edge Pharmacy Services Sponsoring Ophthalmic Anesthesiology Conference
Edge Pharmacy Services is excited to once again be the main conference sponsor for the upcoming Ophthalmic Anesthesiology Society meeting in Chicago on September 28-30.
-
New Revised USP 797 Allergy Compounding
On July 27 USP released a new proposed revision to the 797 sterile compounding guidelines. In particular, there are substantial changes being implemented to allergy immunotherapy treatment set compounding.
-
Edge Brings New Unit-Dose Pharmaceutical Products to Canada
Edge Pharmacy Services, LLC, is excited to announce that it has acquired Apolab ULC of Mississauga, Ontario.
-
Edge Pharmacy Services Expansion Update #5
Our new state of the art cleanroom is undergoing finishing touches and will be ready very soon! This cleanroom includes full six degree-of-freedom robotic automation, which will allow us to...
-
One Needle, One Syringe, One Time Campaign
A new study conducted by the Centers for Disease Control and Prevention (CDC) investigating the prevalence of reusing syringes, needles, and vials for multiple patients was recently published and brings...